Clinigen Group plc Director/PDMR Shareholding (6225T)
October 16 2017 - 2:16AM
UK Regulatory
TIDMCLIN
RNS Number : 6225T
Clinigen Group plc
16 October 2017
16 October 2017
Director's Share Dealing
Clinigen Group plc (AIM: CLIN, 'Clinigen' or the 'Company'), the
global pharmaceutical and services group, announces that it was
notified on 13 October 2017 that the following transaction took
place on 13 October 2017.
Shaun Chilton, Group Chief Executive Officer, sold 100,000
ordinary shares of 0.1 pence each in the Company at a price of 1150
pence per share in order to finance a house purchase.
Following this transaction, Mr Chilton's total beneficial
interest in the Company is 312,943 ordinary shares, representing
approximately 0.27 per cent of the current issued share
capital.
The notification below, made in accordance with the requirements
of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them.
1 Details of the person discharging
managerial responsibilities/person
closely associated
---- --------------------------------------------------------
a) Name Shaun Chilton
---- ---------------------- --------------------------------
2 Reason for the notification
---- --------------------------------------------------------
a) Position/status Group Chief Executive Officer
---- ---------------------- --------------------------------
b) Initial Initial Notification
notification
/Amendment
---- ---------------------- --------------------------------
3 Details of the issuer, emission allowance
market participant, auction platform,
auctioneer or auction monitor
---- --------------------------------------------------------
a) Name Clinigen Group plc
---- ---------------------- --------------------------------
b) Legal Entity N/A
Identifier
---- ---------------------- --------------------------------
4 Details of the transaction(s): section
to be repeated for (i) each type
of instrument; (ii) each type of
transaction; (iii) each date; and
(iv) each place where transactions
have been conducted
---- --------------------------------------------------------
a) Description Ordinary shares of 0.1 pence
of the financial each
instrument, GB00B89J2419
type of
instrument
Identification
code
---- ---------------------- --------------------------------
b) Nature of Sale of shares
the transaction
---- ---------------------- --------------------------------
c) Currency GBP
---- ---------------------- --------------------------------
d) Price(s) Price(s) Volume(s)
and volume(s)
---- ---------------------- --------------- ---------------
1150p 100,000
--------------------------- --------------- ---------------
e) Aggregated 100,000
information
- Aggregated 1150p
volume
- Price GBP1,150,000
- Aggregated
total
--------------------------- --------------------------------
f) Date of 13 October 2017
the transaction
---- ---------------------- --------------------------------
g) Place of London Stock Exchange, AIM
the transaction
---- ---------------------- --------------------------------
-Ends-
Contact Details
Clinigen Group plc Tel: +44 (0) 1283
495 010
Shaun Chilton, Group Chief
Executive Officer
Martin Abell, Group Chief Financial
Officer
Numis Securities Limited Tel: +44 (0) 20
7260 1000
Michael Meade / Freddie Barnfield
(Nominated Adviser)
James Black / Tom Ballard
(Corporate Broking)
RBC Capital Markets - Joint Tel: +44 (0) 20
Broker 7653 4000
Marcus Jackson / Elliot Thomas
/ Jack Wood
Instinctif Partners (media Tel: +44 (0) 20
relations) 7457 2020
Melanie Toyne-Sewell / Alex
Shaw / Deborah Bell Email: clinigen@instinctif.com
About Clinigen Group
Clinigen Group plc (AIM: CLIN) is a global pharmaceutical and
services company with a unique combination of businesses focused on
providing access to medicines. Its mission is to deliver the right
medicine to the right patient at the right time through three areas
of global medicine supply; clinical trial, unlicensed and licensed
medicines.
For more information, please visit www.clinigengroup.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHLIFSTIALSLID
(END) Dow Jones Newswires
October 16, 2017 03:16 ET (07:16 GMT)
Clinigen (LSE:CLIN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Clinigen (LSE:CLIN)
Historical Stock Chart
From Jul 2023 to Jul 2024